Vir Biotechnology (VIR) Change in Accrued Expenses (2018 - 2026)
Vir Biotechnology's Change in Accrued Expenses came in at -$6.21 million for Q3 2026, compared with -$14.83 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Change in Accrued Expenses (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Vir Biotechnology reported Change in Accrued Expenses of -$1.72 million; for FY2025, it was -$9.51 million.
- Going back by year, Change in Accrued Expenses was -$64.02 million in FY2024, -$358.84 million in FY2023, -$15.51 million in FY2022 and $58.5 million in FY2021 (+25.5%).
- The five-year range for quarterly Change in Accrued Expenses is -$288.18 million (Q2 2022) to $433.56 million (Q1 2022).
- Business Quant data shows VIR's Change in Accrued Expenses at $8.39 million (Q2 2026), -$17.22 million (Q1 2026) and $13.32 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 | -6.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6.21 Mn |
| Jun 30, 2026 | 8.39 Mn |
| Mar 31, 2026 | -17.22 Mn |
| Dec 31, 2025 | 13.32 Mn |
| Sep 30, 2025 | -14.83 Mn |
| Jun 30, 2025 | -26.01 Mn |
| Mar 31, 2025 | 18.01 Mn |
| Dec 31, 2024 | -48.49 Mn |
| Sep 30, 2024 | 19.27 Mn |
| Jun 30, 2024 | -4.80 Mn |
| Mar 31, 2024 | -30.00 Mn |
| Dec 31, 2023 | -41.93 Mn |
| Sep 30, 2023 | -47.15 Mn |
| Jun 30, 2023 | -265.73 Mn |
| Mar 31, 2023 | -4.04 Mn |
| Dec 31, 2022 | -80.66 Mn |
| Sep 30, 2022 | -80.24 Mn |
| Jun 30, 2022 | -288.18 Mn |
| Mar 31, 2022 | 433.56 Mn |
| Dec 31, 2021 | 71.99 Mn |
API Access
Vir Biotechnology Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();